Alpha-fetoprotein Structure and Function: Relevance to Isoforms, Epitopes, and Conformational Variants

Experimental Biology and Medicine - Tập 226 Số 5 - Trang 377-408 - 2001
Gerald J. Mizejewski1
1Division of Molecular Medicine, Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, New York 12201

Tóm tắt

Mammalian alpha-fetoprotein (AFP) is classified as a member of the albuminoid gene superfamily consisting of albumin, AFP, vitamin D (Gc) protein, and alpha-albumin. Molecular variants of AFP have long been reported in the biomedical literature. Early studies identified isoelectric pH isoforms and lectin-binding variants of AFP, which differed in their physicochemical properties, but not in amino acid composition. Genetic variants of AFP, differing in mRNA kilobase length, were later extensively described in rodent models during fetal/perinatal stages, carcinogenesis, and organ regeneration. With the advent of monoclonal antibodies in the early 1980s, multiple antigenic epitopes on native AFP were detected and categorized, culminating in the identification of six to seven major epitopes. During this period, various AFP-binding proteins and receptors were reported to inhibit certain AFP immunoreactions. Concomittantly, human and rodent AFP were cloned and the amino acid sequences of the translated proteins were divulged. Once the amino acid composition of the AFP molecule was known, enzymatic fragments could be identified and synthetic peptide segments synthesized. Following discovery of the molten globule form in 1981, the existence of transitory, intermediate forms of AFP were acknowledged and their physiological significance was realized. In the present review, the various isoforms and variants of AFP are discussed in light of their potential biological relevance.

Từ khóa


Tài liệu tham khảo

Tatarinov YS, 1965, Vop Khim SSR, 11, 20

10.1016/S0065-230X(08)60523-0

10.1016/S0140-6736(72)91634-0

Mizejewski GJ, 1985, Alpha-Fetoprotein and Congenital Disorders, 5

10.1016/S0065-230X(08)60483-2

10.1615/CritRevEukarGeneExpr.v5.i3-4.40

10.3181/00379727-215-44143

10.1016/0005-2760(92)90040-3

Crandall BF, 1981, CRC Crit Rev Clin Lab Sci, 15, 1271

Smith CJP, 1980, Biochim Biophys Acta, 605, 1

10.1159/000217540

10.1159/000030024

10.1159/000030023

10.1159/000030022

Bychkova VE, 1993, Biochem Mol Biol, 4, 133

10.1159/000217876

Uriel J., 1989, J Nucl Med Allied Sci, 33, 12

10.1016/S0021-9258(20)88249-0

10.1016/S0021-9258(17)32429-8

10.1126/science.2374930

10.1021/bi00294a043

10.1093/nar/13.22.8007

10.1016/S0021-9258(18)38107-9

10.1016/S0021-9258(17)37482-3

10.1016/0378-1119(94)00745-E

Gutteridge JMC, 1986, Biochem Biophys Acta, 869, 119

10.1083/jcb.122.1.243

Constans J., 1992, Exp Clin Immunogenet, 9, 161

Ohkawa K, 1987, Comp Biochem Physiol, 88, 497

10.1016/S1095-6433(99)00088-4

10.1016/S0021-9258(18)34648-9

10.1016/S0021-9258(18)50625-6

10.1126/science.2432657

10.1016/B978-0-12-665080-8.50011-8

10.1016/S0021-9258(18)32512-2

Petropoulos C, 1985, Cancer Res, 45, 5762

10.1016/0006-291X(86)91005-3

10.1016/S0006-291X(82)80080-6

Lemire JM, 1991, Cancer Res, 51, 4656

10.1016/0003-9861(89)90028-3

10.1016/0006-291X(92)91674-F

10.1021/bi00419a014

Morinaga T, 1982, Oncodev Biol Med, 3, 301

10.1016/0006-291X(80)90446-5

Sarcione EJ, 1983, Cancer Res, 43, 3739

10.1002/ijc.2910350306

10.1210/mend.12.10.0184

10.1074/jbc.275.10.7158

10.1002/bies.950150610

10.1021/bi990630h

10.1615/CritRevEukarGeneExpr.v7.i1-2.20

Lazarevich NL, 2000, Biochim (Moscow), 65, 117

10.1016/S0168-8278(99)80232-3

Ido A, 1995, Cancer Res, 55, 3105

10.1038/sj.gt.3300870

10.1007/s11626-999-0012-x

Vollmer CM, 1999, Cancer Res, 59, 3064

Butterfield LH, 1999, Cancer Res, 59, 3134

10.1002/(SICI)1097-0290(19991020)65:2<160::AID-BIT5>3.0.CO;2-U

10.1677/jme.0.0140101

10.1074/jbc.270.17.10204

10.1089/dna.1996.15.1063

10.1016/0024-3205(94)00401-D

10.1016/0009-8981(76)90551-9

10.1111/j.1365-3083.1978.tb03937.x

10.1111/j.1365-3083.1978.tb03936.x

Sarcione EJ, 1987, Dis Markers, 5, 75

Naketa K, 1983, Oncodev Biol Med, 4, 101

Mizejewski GJ, 1987, Biological Activities of Alpha-fetoprotein, 162

10.1016/0009-8981(82)90040-7

10.1093/clinchem/31.10.1692

Goncharova O, 1999, Tumor Biol, 20, 42

Torres JM, 1992, Isolation and characterization. Biochem Biophys Acta, 1159, 60

10.1172/JCI116021

10.1073/pnas.82.10.3301

10.1159/000217864

10.1016/0006-291X(84)91236-1

10.1016/0165-6147(86)90291-9

10.1016/S0959-440X(05)80111-3

10.1016/0167-0115(81)90007-0

10.1073/pnas.88.8.3065

10.1074/jbc.275.3.1521

Wen W, 1999, Cancer Res, 59, 6052

Carroway RE, 1987, J Biol Chem, 262, 5969

10.1016/S0065-3233(08)60065-0

10.1021/bi00234a032

10.1016/0303-7207(96)03762-8

Terentiev AA, 1999, Tumor Biol, 20

Salmasi JM, 1999, Tumor Biol, 20

Terentiev AA, 1999, Tumor Biol, 20

10.1016/0955-0674(92)90105-L

10.1016/S0021-9258(18)71604-9

Nomizu M, 1993, Cancer Res, 53, 3459

10.1083/jcb.120.2.513

10.1016/0092-8674(89)90945-8

10.1096/fasebj.4.2.2404817

10.1006/bbrc.1999.2021

10.1016/0092-8674(92)90600-H

10.1126/science.1279805

Bilozur ME, 1988, Dev Biol, 174, 1159

10.1083/jcb.113.6.1475

10.1096/fasebj.6.7.1532944

10.1126/science.2961059

10.1021/bi00222a011

10.1016/0005-2736(93)90094-G

10.1016/S0021-9258(18)98498-X

10.1016/0896-6273(91)90261-W

10.1016/0012-1606(90)90082-T

10.1016/S0021-9258(20)89455-1

10.1016/0092-8674(91)90451-4

10.1177/153537029922200203

10.1016/S0021-9258(20)80715-7

10.1016/S0021-9258(18)86988-5

10.1016/S0021-9258(18)55134-6

10.1073/pnas.80.9.2733

10.1006/bbrc.1993.2357

10.1073/pnas.80.15.4604

10.1016/0005-2795(73)90218-3

10.1016/0005-2795(79)90488-4

Ishiguro T, 1983, Tumor Biol, 6, 195

Taketa K, 1985, Tumor Biol, 6, 519

Taketa K, 1985, Tumor Biol, 6, 533

10.1016/0167-4838(85)90277-8

10.1002/elps.1150191506

10.1002/elps.1150191039

10.1136/bmj.1.6168.920

10.1002/ijc.2910220502

10.1111/j.1600-0897.1983.tb00216.x

Ohta M, 1998, Acta Med Okayama, 52, 27

10.1111/j.1365-3083.1981.tb00179.x

10.2957/kanzo.22.1559

10.1016/S0168-8278(99)80016-6

10.1016/0022-4731(90)90224-G

10.1016/S0300-9084(77)80149-1

10.1073/pnas.73.8.2857

10.1016/S0021-9258(19)45104-1

10.1016/S0021-9258(17)38047-X

10.1016/S0021-9258(19)86358-5

10.1016/0003-2697(91)90557-A

10.1111/j.1749-6632.1983.tb32847.x

10.1073/pnas.73.12.4641

Pekkala-Flagan A, 1982, J Immunol, 128, 1163, 10.4049/jimmunol.128.3.1163

10.3109/08820137809033884

10.1111/j.1749-6632.1975.tb25407.x

10.1016/0145-305X(83)90062-9

10.1111/j.1600-0897.1984.tb00285.x

Hassoux R, 1978, Comp Rend Acad Sci (Paris), 287, 395

10.1002/eji.1830050103

Sheppard HW, 1977, Studies on mice. J Immunol, 119, 91

10.1038/250050a0

10.1038/259222a0

Mizejewski GJ, 1979, Arch Immunol Exp Ther, 27, 655

10.1093/jnci/54.6.1361

10.1016/0090-1229(78)90055-7

10.1159/000217588

10.1159/000030020

Christiansen M, 1994, J Tumor Marker Oncol, 9, 57

10.1159/000030021

10.1016/0161-5890(80)90150-9

10.1016/0161-5890(82)90281-4

Van Heyningen V, 1982, Monoclonal antibodies to human AFP: Analysis of the behavior of three different antibodies. Immunol Methods, 50, 123

10.1016/0277-5379(83)90201-8

10.1089/hyb.1984.3.177

10.1016/0022-1759(88)90266-9

10.1016/0165-2478(90)90203-3

10.1016/0300-9084(90)90034-E

10.1016/0161-5890(91)90112-W

10.1016/0165-2478(94)90184-8

Bei R, 1999, Cancer Res, 59, 5471

10.1023/A:1006484223325

10.1016/0014-5793(81)80642-4

10.1016/0014-5793(95)00379-N

10.1021/bi970332p

10.1016/S0014-5793(97)00606-6

Dudich IV, 1998, Tumor Biol, 19

10.1006/jmbi.1999.3228

10.1093/protein/12.7.581

10.1002/(SICI)1097-0134(20000201)38:2<189::AID-PROT7>3.0.CO;2-F

10.1110/ps.8.3.554

10.1016/S1359-0278(97)00023-0

10.1096/fasebj.10.1.8566545

10.1021/bi9723010

10.1074/jbc.275.5.3042

10.1073/pnas.93.26.15051

10.1021/bi00148a018

10.1021/bi9522460

10.1006/jmbi.1998.2440

Clark AC, 1999, coli and murine dihydrofolate reductase. J Mol Biol, 285, 1777

10.1073/pnas.96.13.7250

10.1074/jbc.271.44.27595

10.1002/(SICI)1097-0134(19991115)37:3<321::AID-PROT1>3.0.CO;2-L

Pattus F, 1990, Exp, 46, 180

10.1038/354408a0

10.1098/rstb.1995.0043

10.1016/0014-5793(88)80485-X

10.1016/0014-5793(95)00004-S

10.1016/S0960-9822(00)00301-8

10.1002/j.1460-2075.1988.tb02923.x

10.1006/jtbi.1995.0180

10.1016/S1359-0278(96)00020-X

Thomasson WA, 1998, Fed Am Soc Exp Biol, Bethesda, MD. Vol, 1, 1

10.1096/fasebj.10.1.8566529

10.1016/S0962-8924(99)01580-9

Lorimer GH, 1996, FASEB J, 10

10.1096/fasebj.10.1.8566542

10.1096/fasebj.10.1.8566543

10.1126/science.2756425

10.1002/j.1460-2075.1991.tb08044.x

10.1016/S0968-0004(00)89100-8

10.1126/science.271.5255.1493

10.1016/S0968-0004(99)01445-0

10.1002/pd.1970101108

10.1111/j.1471-0528.1986.tb07919.x

10.1016/S0140-6736(88)92930-3

10.1002/pd.1970110820

10.1016/0002-9378(85)90469-7

10.1002/hep.510290322

10.1111/j.1442-200X.1998.tb01409.x

10.1097/00000658-199001000-00009

10.1073/pnas.90.20.9480

10.1016/S0021-9258(17)37316-7

10.1016/S0021-9258(17)41794-7

10.1016/S0021-9258(18)99944-8

10.1016/S0021-9258(17)46834-7

Yehiely F, 1992, Cell Growth Diff, 3, 803

10.1021/bi00151a036

10.1073/pnas.90.1.1

10.1074/jbc.270.7.3063

10.1126/science.7355290

10.1146/annurev.ge.24.120190.001025

10.1016/S0021-9258(19)30090-0

Chuang DT, 1995, J Nutr, 125, 17665

10.1172/JCI115363

10.1016/1074-5521(95)90281-3

10.1016/S0962-8924(98)01368-3

10.1002/j.1460-2075.1992.tb05434.x

10.1002/tera.1420140206

Rochelson B, 1990, Obstet Gynecol, 75, 59, 10.1097/00006250-199004001-00012

10.1056/NEJM198906013202203

10.1016/0169-328X(91)90033-T

10.1016/0306-9877(94)90012-4

Ananthan J, 1985, Science, 317, 522

10.1016/S0962-8924(98)01267-7

Liautard JP, 1990, CR Acad Sci, 311, 385

10.1111/j.1471-0528.1979.tb10575.x

10.1016/S0022-2275(20)37440-X

Haddow JE, 1979, J Lab Clin Med, 94, 344

10.1111/j.1749-6632.1975.tb25397.x

10.1172/JCI118277

Schneider H, 1988, Trophablast Res, 3, 189

10.1038/2221296a0

Kupfermine MJ, 1993, Obstet Gynecol, 82, 266

10.1016/0002-9378(95)91336-X

10.1097/00006254-199011000-00001

10.1016/S0021-9258(18)61391-2

10.1002/jcp.1041500305

Severin SE, 1995, Biochem Mol Biol Int, 37, 385

10.1006/cbir.1998.0201

Severin SE, 1997, Biochem Mol Biol Int, 43, 1081

Severin SE, 1996, Tumor Target, 2, 299

10.1016/0167-4889(91)90095-F

10.1016/S0014-5793(99)00440-8

10.1016/S0083-6729(08)61013-4

10.3181/00379727-208-43824B

10.3181/00379727-217-44238

10.1002/(SICI)1097-0215(19980209)75:4<596::AID-IJC17>3.0.CO;2-7

10.1016/S0002-9378(11)91441-0

10.1002/(SICI)1097-0223(199709)17:9<884::AID-PD163>3.0.CO;2-N

Gershwin NME, 1980, J Natl Cancer Inst, 64, 145

10.1016/S0197-1859(81)80073-8

Mizejewski GJ, 1987, Biological Activities of Alpha-Fetoprotein, 71

10.1530/jrf.0.0850177

10.1095/biolreprod42.6.887

10.1083/jcb.61.3.823

10.1016/S0143-4004(83)80019-8

Hamel S, 1987, Biological Activities of Alpha-Fetoprotein, 1, 167

10.1210/endo-126-1-669

10.1210/endo-129-1-217

Jacobson HI, 1990, Cancer Res, 50, 415

10.1159/000218013

Semenkova LN, 1998, Tumor Biol, 19, 261, 10.1159/000030016

Semenkova LN, 1988, Tumor Biol, 19

Semenkova LN, 1998, Eur Cytokine Network, 9

Dudich I, 1998, Eur Cytokine Network, 9

Dudich E, 1988, Eur Cytokine Network, 9

10.1046/j.1432-1327.1999.00868.x

Dudich E, 1999, J Interferon Cytokine Res, 19

10.1159/000029972

Goncharova O, 1999, Tumor Biol, 20, 42

Mizejewski GJ, 1986, Tumor Biol, 7, 19

Bennett JA, 1993, J Cancer Res Clin Oncol, 34, 244

10.1016/S0304-4165(99)00030-6

10.1038/bjc.1985.123

Lobenhofer EK, 2000, Cell Growth Diff, 11, 99

Musgrove EA, 1994, Semin Cancer Biol, 5, 381

10.1128/MCB.14.3.2066

10.1006/bbrc.1997.6746

Razandi M, 1999, Studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol, 13, 307

10.1007/BF01832359

10.1096/fasebj.13.1.1

10.1074/jbc.272.23.15011

10.1016/S0968-0004(99)01538-8

10.1074/jbc.274.45.32248

10.1111/j.1469-7793.1999.0005z.x

10.1016/S0955-0674(99)00077-0

Bennett JA, 1998, Clin Cancer Res, 4, 2877

10.1159/000029972

Moro R, 1986, Tumor Biol, 7, 115

Wu JT, 1987, Clin Physiol Biochem, 5, 85

10.1016/0300-483X(90)90096-Y

10.1073/pnas.88.8.3102

Nishi S, 1993, Tumor Biol, 14

Jaziri M, 1992, Biochem Biophys Acta, 1160, 251

10.1126/science.282.5396.2088

10.1172/JCI119112

Marquardt T, 1995, Eur J Cell Biol, 66, 268

Oksche A, 1996, Mol Pharmacol, 50, 820

10.1182/blood.V79.12.3212.bloodjournal79123212

10.1182/blood.V87.12.5085.bloodjournal87125085

10.1182/blood.V87.10.4164.bloodjournal87104164

10.1056/NEJM199812033392307

10.1128/MCB.16.7.3853

10.1093/oxfordjournals.aje.a009691

10.1093/jnci/92.12.1001

Janerich DT, 1975, Am J Epidem, 102, 456

Jacobson HI, 1989, Biological Activities of AFP, 2, 93

10.1093/oxfordjournals.aje.a115220

10.1093/jnci/81.20.1571

10.1038/35015579

10.1002/pd.1970020108

10.1111/j.1471-0528.1985.tb01106.x

10.1038/labinvest.3780090

Lamerz R., 1997, Anticancer Res, 17, 2927

10.1159/000056521

10.1016/0014-5793(75)80042-1

10.1159/000217697

Thông tin
Thông tin xuất bản

Experimental Biology and Medicine

Tập 226 Số 5

377-408

Thông tin tác giả